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Background: Depression and diabetes cause significant burden for patients and the healthcare system and, when
co-occurring, result in poorer self-care behaviors and worse glycemic control than for either condition alone.
However, the clinical management of these comorbid conditions is complicated by a host of patient, provider, and
system-level barriers that are especially problematic for patients in rural locations. Patient-centered medical homes
provide an opportunity to integrate mental and physical health care to address the multifaceted needs of complex
comorbid conditions. Presently, there is a need to not only develop robust clinical interventions for complex
medically ill patients but also to find feasible ways to embed these interventions into the frontlines of existing
primary care practices.
Methods/design: This randomized controlled trial uses a hybrid effectiveness-implementation design to evaluate
the Healthy Outcomes through Patient Empowerment (HOPE) intervention, which seeks to simultaneously address
diabetes and depression for rural veterans in Southeast Texas. A total of 242 Veterans with uncontrolled diabetes
and comorbid symptoms of depression will be recruited and randomized to either the HOPE intervention or to a
usual-care arm. Participants will be evaluated on a host of diabetes and depression-related measures at baseline
and 6- and 12-month follow-up. The trial has two primary goals: 1) to examine the effectiveness of the intervention
on both physical (diabetes) and emotional health (depression) outcomes and 2) to simultaneously pilot test a
multifaceted implementation strategy designed to increase fidelity and utilization of the intervention by coaches
interfacing within the primary care setting.
Discussion: This ongoing blended effectiveness-implementation design holds the potential to advance the
science and practice of caring for complex medically ill patients within the constraints of a busy patient-centered
medical home.
Trial registration: Behavioral Activation Therapy for Rural Veterans with Diabetes and Depression: NCT01572389.
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Depression and diabetes cause significant burden for pa-
tients and the healthcare system [1,2]. Individuals with
diabetes have up to a 24% increased risk of developing
depression [3], and individuals with depression have
increased risk of developing type 2 diabetes [4]. When
co-occurring with diabetes, depression is associated with
poorer self-care behaviors and worse glycemic control
than in diabetes without depression [5]. Unfortunately, the
clinical management of co-occurring diabetes and depres-
sion is complicated by a host of patient, provider, and
system factors that, ultimately, lead to limited opportun-
ities for comprehensive integrated healthcare treatments,
especially for patients in rural locations [6,7].
Effective interventions exist for depression [8] and dia-
betes [9], but these interventions often have limited
impact when depression and diabetes co-occur [10,11].
There is currently a need to develop interventions that
simultaneously target diabetes and depression [11], with
several recent studies showing promising preliminary
results [12,13]. Blended diabetes and depression inter-
ventions offer the potential to improve broad patient out-
comes but also offer opportunities to integrate physical
and mental health care within interprofessional team-
based healthcare settings, [13,14].
Unfortunately, the limited availability of specialized
mental and behavioral health providers is a significant
barrier to integrated health care in primary care settings
and is especially problematic for rural patients [15]. In re-
sponse, researchers and clinicians have tried to increase
the availability of providers and behavioral health services.
For example, training non-mental health clinicians to pro-
vide basic mental health services has been shown to im-
prove the provision of mental health care in primary care
settings (e.g., Areán et al. [16]). Other modifications in-
clude the use of telephone-based mental health care,
which eases travel burden on patients, and, in some con-
texts, appears to perform as well as face-to-face care, with
lower attrition rates [17]. These techniques may be espe-
cially important for rural populations, which have higher
rates of diabetes than urban populations [18] and limited
access to both diabetes and mental health care [19,20].
From a healthcare-system perspective, the patient-centered
medical home (PCMH), a primary focus of healthcare
reform in the United States, offers opportunities for im-
proved access to integrated and coordinated diabetes and
depression care. Unfortunately, a dearth of research has
assessed coordinated or blended models of diabetes and
depression care in PCMHs. In 2010, the Veteran’s Health
Administration began implementing a PCMH model
known as the Patient-Aligned Care Team (PACT). PACTs
are situated in primary care clinics and are intended to
improve the provision of patient-centered care by placing
the patient at the center of a care team that includes aprimary care provider, a registered nurse, a licensed voca-
tional nurse or health technician, and a clerical associate.
PACTs are responsible for the coordination of patient
healthcare services and represent an ideal setting for the
integration of mental and physical healthcare practices.
The current article describes a Veterans’ Affairs (VA)
Health Services Research & Development-funded multi-
clinic, patient-level randomized controlled trial designed
to examine clinical effectiveness and preliminary imple-
mentation outcomes of a blended depression and dia-
betes behavioral health coaching intervention. Delivered
over the telephone by PACT clinicians and trained be-
havioral health coaches, the intervention is intended for
rural Veterans with uncontrolled diabetes and clinically
elevated symptoms of depression. The trial has two pri-
mary goals: 1) to examine the effectiveness of the inter-
vention on both physical (diabetes) and emotional health
(depression) outcomes and 2) to simultaneously pilot
test a multifaceted implementation strategy designed to
increase fidelity and utilization of the intervention by
coaches interfacing within the primary care setting. This
simultaneous focus on effectiveness and implementation
outcomes, defined by Curran et al. [21] as a hybrid
effectiveness-implementation trial, is intended to reduce
the translation lag from intervention development to inter-
vention implementation and adoption in routine practice.
However, hybrid designs require a balance between the
need for internal control (e.g., scientific manipulation) and
external validity (e.g., ability of the study to generalize to
the intended clinical care setting). This article outlines
such a hybrid design, including decisional points related
to the study team’s desire to explore patient-, clinician-,
and system-level outcomes of a blended diabetes and de-
pression coaching intervention.
Methods
The Healthy Outcomes through Patient Empowerment
(HOPE) study is being conducted at the Michael E.
DeBakey Veterans Affairs Medical Center (MEDVAMC)
and six affiliated community-based outpatient clinics
(CBOCs) in Southeast Texas. The study is approved by
the Baylor College of Medicine Institutional Review
Board and the MEDVAMC Research and Development
Committee.
Using a hybrid effectiveness-implementation design, the
project relies heavily on the RE-AIM evaluation frame-
work (Reach, Effectiveness, Adoption, Implementation,
Maintenance) [22,23] (see Figure 1). Although we discuss
the effectiveness and implementation aspects separately in
this article, the application and evaluation of procedures
within hybrid trials of this nature occur simultaneously
and are often contingent upon one another. For example,
the eventual success of the clinical intervention will be im-
pacted by the success (or failure) of the implementation
Figure 1 Re-aim evaluation framework.
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intervention.
Clinical effectiveness
Identification and recruitment of participants
The study will enroll 242 participants with uncontrolled
diabetes (i.e., average HbA1c values ≥ 7.5% for the last
year) and coexistent, clinically elevated symptoms of de-
pression (i.e., the nine-item Patient Health Questionnaire
[PHQ-9] score ≥ 10). Using an unequal randomization
design, we will randomize 60% of participants (n = 145)
to receive blended diabetes/depression behavioral health
coaching for six months (active intervention), followed
by six months without coaching (maintenance period);
the other 40% (n = 97) will receive enhanced usual
care (EUC), which includes the provision of educa-
tional materials. Primary care team members (i.e., the
primary care physician, registered nurse, licensed vo-
cational nurse) of each consented participant who com-
pletes the baseline interview will be informed that the
Veteran endorsed mild, moderate or severe symptoms
of depression and has consented to participate in a
study related to the management of diabetes and de-
pression. Notification will occur through the electronic
medical record (EMR) system and secure messaging
platforms.
Potential participants are being identified through VA
databases pulled from the Veterans Integrated Service
Network for Southeast Texas 16 data warehouse. These
data provide the study team with a list of patients with
primary care appointments within the last 24 months
and an International Classification of Diseases, Ninth
Revision code for diabetes (250.××). The study’s data
analyst runs the list through an analytic algorithm for
geographic exclusion (i.e., patients must reside at least
20 miles from the MEDVAMC and/or receive primary
care at a CBOC, to ensure rural status) and uncontrolled
glucose (i.e., average A1C levels ≥ 7.5% for at least one
year). Eligibility criteria for the study are designed to be
as broad as possible to closely resemble the targeted
patient population and to provide the greatestexternal validity for the intervention. Patients are ex-
cluded only for factors that would make a telephone-
based coaching intervention delivered by primary care
providers inappropriate (e.g., active suicidal ideation; se-
vere cognitive impairment; severe mental health condi-
tion, such as psychosis or active substance-abuse
disorder; significant vision or hearing loss). Research as-
sistants conduct chart reviews to confirm glucose-control
status and geographic location, as well as to exclude
individuals with psychotic disorders, cognitive impair-
ment, or active substance-abuse issues. For safety, the
chart review is also used to exclude patients with a
history of significant hypoglycemic events. Remaining
patients are sent an opt-out letter and directed to call a
hotline number if they are not interested in participating.
Calls are made to all potential participants who do not
opt-out. Interested participants complete a telephone-
based screening interview with a research assistant to
confirm eligibility, based on a brief screening for depres-
sion and to assess for factors that would preclude en-
gaging in the telephone-based intervention (e.g., hearing
loss, lack of regular access to a telephone, relocation out-
side Southeast Texas). We also exclude patients who do
not endorse symptoms of depression on a brief screening
for depression using the PHQ [24,25] during the screen
appointment. Patients endorsing active suicidal ideation
and requiring immediate mental health attention at any
point in the recruitment process are referred for appropri-
ate services and excluded from the study.
Eligible participants who provide informed consent
complete the baseline telephone assessment. Participants
scoring < 10 on the PHQ-9 at the baseline assessment
are excluded from further participation in the study. Par-
ticipants meeting the inclusion criterion for depression
status at baseline are then asked to confirm their eligibil-
ity on the glycemic-control criterion with a baseline
blood draw. Participants with A1C levels < 7.5% are ex-
cluded. Upon final determination of inclusion, partici-
pants are randomized to HOPE or EUC. Participants are
compensated only for research assessments: $30 for
participation in baseline, six- and 12-month assessments
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tification and recruitment is presented in the form of a
CONSORT diagram (see Figure 2).
Clinical intervention
HOPE delivers six biweekly (twice a month) 30-minute
sessions and three monthly 15-minute follow-up sessions
over a six-month period. All sessions are completed over
the telephone to ease treatment burden on participants.
Participants receive two “core” sessions that provide foun-
dational information and activities related to diabetes,
depression, and setting effective goals and action plans.
During the core sessions, participants also select skill-
based activities from the intervention manual (e.g., mod-
ules) that most closely align to their interests and most
pressing needs (see Table 1). These “elective modules” areFigure 2 Consort diagram.provided during sessions three through six. The final three
sessions (seven through nine) provide opportunities for
solidification of skills and maintenance of lifestyle modifi-
cations. A detailed description of the HOPE intervention,
along with pilot data from a small open trial, can be found
in a previously published study [12].
The HOPE intervention is based on principles of goal
setting and action planning [26-28] and evidence-based
psychotherapy, including cognitive-behavioral therapy
[29,30] and motivational interviewing [31,32]. As such,
HOPE emphasizes the relationship between the coach
and patient as a necessary element for change and lever-
ages that relationship to implement focused skill-based
techniques designed to help patients improve their physical
and/or emotional self-management behaviors. Sessions are
based on the concept of patient self-management and the
Table 1 HOPE intervention modules
Session 1 Introduction to HOPE
• Introduction to HOPE and how it can help
• Rapport Building
• Introduction to behavioral activation
• Setting behavioral activation goal
Session 2 Setting goals and making action plans
• Introduction to principles of goal setting and
action planning






• Connections between activities and mood
• Benefits of increasing pleasant and meaningful
activities
• Setting goal and action plan to increase pleasant
activities
Using thoughts to improve wellness
• Connections between thoughts and mood
• Recognizing and reducing unhelpful thinking
• Setting goal and action plan to use thoughts to
improve mood
Eating wisely
• Information about healthy eating
• Setting goals and action plans to improve diet:
◦ Limiting portions
◦ Controlling carbohydrates
◦ Increasing fruit/vegetable consumptions
◦ Reducing unhealthy fat intake
Being physically active
• Benefits of physical activity
• Setting goals and action plans to increase activity
Managing your medications
• Importance of taking medications as prescribed
• Setting goals and action plans to increase activity
related to:
◦ Knowing medications
◦ Choosing the right diabetes medication
◦ Keeping a schedule for taking medications
◦ Medications for mood
Learning how to relax
• Relationships between stress, anxiety and worry
• Setting goals and action plans to increase activity
related to:
◦ Deep breathing to reduce stress and tensions
◦ Imagery to reduce stress and tension
Sessions 7–9
(follow-up)
Adjusting action plans and overcoming obstacles
• Checking on progress and resolving barriers to
goal attainment
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dress both diabetes and depression. The primary skill-
based technique is that of behavioral activation, which
encourages patients to set focused behavior-oriented
goals and action plans to address their physical and emo-
tional health concerns. Diabetes skill management focuses
on diabetes awareness and the role of diet, exercise, and
medication management in improving diabetes outcomes.
Depression skill management is based on traditional cog-
nitive and behavioral strategies, such as identification of
maladaptive thinking, behavioral activation, and relax-
ation. Notably, the diabetes and depression intervention
skill “modules” are viewed as overlapping, with the poten-
tial to improve the management of either depression or
diabetes (e.g., depression may be improved by exercise or
diet skills, whereas diabetes may be improved by behav-
ioral activation).Intervention providers – “coaches”
The study enlists the participation of coaches embedded
in primary care, who deliver the HOPE intervention
and subsequently communicate with each participant's
primary care team through the EMR, secure (instant)
messaging, and telephone contacts. Such contacts focus
on communicating the participant’s ongoing behavioral
health-improvement goals and addressing any notable
physical or emotional health changes that might require
further intervention (e.g., hypoglycemia, medication issues,
or intent or plan for self-harm). See the Implementation
Section for additional details.
Outcome measures, analyses, and power
Clinical effectiveness is being measured with depression
scores on the PHQ-9 [33] and HbA1c values at post-
treatment (six months) and at a 12-month follow-up. To
minimize potential bias, all self-report measures will be
collected by blinded independent evaluators.
Additional data are collected at six- and 12-month
follow-up assessments, including the following: the a)
Problem Areas in Diabetes Questionnaire [34] to assess
changes in diabetes distress; b) Penn State Worry Ques-
tionnaire [35] to assess changes in worry/anxiety; and c)
Goal-Setting Evaluation Tool for Diabetes[36] to assess
goal-setting quality. Other study variables include demo-
graphic variables, healthcare use, self-efficacy, comorbid
physical and mental conditions and other psychological
factors.
All analyses will be done on an intention-to-treat basis.
Hierarchical linear models will be used to assess differ-
ences in outcomes measures between baseline and six- and
12-month follow-ups. Effect sizes will be compared
between treatment and control groups at those time
points.
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patients randomized to the treatment group and 40%
randomized to EUC. A final cohort of 182 participants
(109 in the active intervention arm and 73 in the control
arm) at 12-month follow-up (i.e., recruitment of 242 to
allow for 25% attrition) provides 80% power to detect an
effect size of 0.45. This effect size represents a clinically
meaningful difference in HbA1c of 0.5 (SD = 1.1) [37].
For the PHQ-9, a reduction of 5 points or greater will be
considered clinically significant [38-40]). Our sample
size of 109 intervention participants and 73 controls will
have 80% power to detect a change as small as 1.5 points
in the PHQ-9 score with a two-sided alpha = 0.05.
Implementation
As a hybrid type 2 trial [21], this study assesses effective-
ness and implementation outcomes simultaneously to
ensure that, if effective, the HOPE intervention will be
well positioned for use within existing primary care set-
tings. As a second aim, the current trial seeks to examine
and pilot a collection of training- and facilitation-based in-
terventions designed to enhance the adoption and imple-
mentation of the HOPE intervention by frontline primary
care clinicians. Targeted care providers include nurses, so-
cial workers, pharmacists, registered dietitians, psycholo-
gists, and physician assistants.
The RE-AIM framework was used to define salient
study constructs and to guide evaluation of the imple-
mentation strategy, which is focused on Adoption and
Implementation [22]. For the purposes of this study,
adoption refers to the percent and representativeness of
clinic staff and settings using the intervention relative to
the total number of clinics and clinicians approached.
Although broad adoption statistics are being collected,
additional details, including barriers and facilitators to
using the intervention, are also being collected, using
survey and qualitative interview methods. Implementa-
tion, as defined by RE-AIM, refers to the consistency or
fidelity in delivering the intervention across staff and set-
tings. Fidelity is being measured using audio taped ses-
sion reviews as part of the coaching audit and feedback
procedures (see below).
Coaches
The intervention is being delivered by clinician health coa-
ches with varying professional backgrounds (e.g., nurses,
clinical social workers, dieticians, etc.). Given the broader
effectiveness goals of the study, interventionists include
“study coaches” and “PACT coaches.” Study coaches are
defined as clinicians providing care as part of their duties
to the study project itself. Study coaches provide care
outside the physical setting of primary care, are not for-
mal members of the PACT, and communicate with the
PACT exclusively at a distance through the EMR, instantmessaging, and telephone. Study coaches are included in
the project to simulate opportunities to reach patients
using care providers who are not directly associated with
the PACT (e.g., telephone-based care-management ser-
vices that are not physically located in the primary care
treatment setting). Nonprimary care-based coaches may
improve access to comprehensive healthcare services for
patients in rural and underserved geographic locations
where resources may be limited. For the purposes of
this investigation, it is anticipated that study coaches
will include an interprofessional mix of professionals,
such as masters-level providers and trainees from psych-
ology, social work and pharmacy. Study coaches will be
identified by the project team through outreach to non-
primary care programs, such as hospital-based specialty
care service organizations and training programs. Not-
ably, study coaches are viewed as distinct from PACT
coaches due to their physical presence outside the primary
care setting.
PACT coaches, in contrast to study coaches, are for-
mal members of the PACT and assimilate the HOPE
intervention into their regular primary care clinical du-
ties. PACT coaches are clinicians who are able to deliver
telephone-based coaching within their scope of profes-
sional practice. Future implementation of PACT coaches
will occur through the training of existing clinicians
within the primary care setting.
Implementation strategy
Several implementation techniques are being used to
support coaches as they attempt to adopt and effectively
use the HOPE intervention. Implementation techniques
are multifaceted and target both the ability of coaches to
accurately and effectively use the content and proce-
dures of the intervention, as well as provide support for
coaches in their ability to incorporate the intervention
into the primary care setting. Initial training and facilita-
tion, developed in collaboration with an advisory council
consisting of frontline PACT clinicians, occur through
a focused coach training workshop and a subsequent
pairing of coaches with HOPE mentors. Mentors are
members of the study team who have behavioral-change
expertise. In addition, mentors are educators with skills in
helping others with professional development. Mentors
use audit and feedback of coach-session audiotapes as a
foundation for coach professional development. A third
approach relates to the study’s goal to disseminate inter-
vention efforts to PACT providers and the larger PACT
through the use of structured medical-record note
templates designed to embed treatment progress notes
within each patient’s EMR, regular facilitation calls with
coaches to share experiences across intervention sites, and
regular HOPE newsletters delivered to a broad audience
of primary care clinicians and leaders.
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over two, two-hour computer-aided telephone sessions.
The distance-based learning format improves feasibility
and has the added benefit of modeling effective tele-
phone communication, a necessary skill for coaches provid-
ing a telephone-based treatment. The first coach training
session covers background information on diabetes and
depression, the objectives and core components of HOPE,
including HOPE’s approach to patient care; the coaching
relationship; and evidence-based techniques to treat dia-
betes and depression, such as motivational interviewing,
behavioral activation, and goal setting. The second coach
training session reviews specific details of treatment ses-
sions and describes how to apply the principles learned
during the first training session. Each training session uses
a variety of interactive elements to provide coaches with
the practical elements of using HOPE, such as computer-
aided demonstrations of techniques, audio recordings and
discussions of simulated patient sessions. Telephone train-
ings are supplemented with materials provided to coaches
through the study website, including a treatment manual,
patient workbook, and optional concept reviews on dia-
betes and depression.
Mentoring with audit and feedback HOPE mentors
augment the telephone training and facilitate advanced
levels of practice through the use of audit and feedback
procedures. All coaches audio record treatment sessions
with HOPE participants. Mentors rate sessions using a
clinician fidelity form, developed from a prior study [41].
Mentors listen to all sessions for each coach’s first pa-
tient and review a random set of sessions on a quarterly
basis for all subsequent patients. Coaches remain in con-
tact with mentors throughout the course of the trial to
discuss clinical cases by email or telephone.
Facilitation On a monthly basis, coaches have the op-
tion of participating in a conference call with other
HOPE coaches, mentors, and members of the study staff
(e.g., principal investigators, research coordinators). These
calls are intended to help coaches overcome practice and
organizational barriers to the implementation of the HOPE
intervention. HOPE staff organize and administer the call;
however, the needs and interests of the coaches largely dic-
tate the agenda, so as to increase coach-to-coach interac-
tions and sharing. To accommodate coaches’ schedules,
the calls are optional, with the frequency of calls adjusted
according to coach preference. Minutes from the meeting
are posted on the HOPE website, with summaries provided
in the HOPE newsletter for coaches unable to attend.
Outcome measures and analyses
Implementation analytics are largely descriptive in na-
ture. The RE-AIM facet of Adoption will be measured asthe percent and representativeness of clinic staff and set-
tings using the intervention relative to the total number
of clinics and clinicians approached. The RE-AIM facet
of Implementation will be assessed through formal fidel-
ity ratings provided by mentors.
Discussion
HOPE is a patient-level randomized controlled trial de-
signed to streamline and improve the transition from re-
search to practice by simultaneously examining the clinical
effectiveness and implementation potential of a telephone-
based approach to blended diabetes/depression care for
the primary care setting. From an effectiveness standpoint,
the blended diabetes and depression focus, along with the
multifaceted patient-centered approach of the intervention,
represent novel clinical enhancements. The study also em-
ploys a comprehensive implementation strategy to support
the use of the intervention within the primary care setting,
provides additional innovation both in terms of opportun-
ities to enhance treatment effectiveness (e.g., improved
communication between interventionists and the primary
care treatment team) and in terms of providing opportun-
ities to better understand the potential for frontline clini-
cians to effectively use the HOPE program within their
existing patient population. It is anticipated that a focus
on implementation will facilitate a better understanding of
the challenges and opportunities for future dissemination
of this blended intervention approach should the project
produce significant positive clinical outcomes. Notably,
project implementation efforts have been closely aligned
with current VA clinical practice and policies. For ex-
ample, services obtained as part of this intervention are
consistent with healthcare coverage policies for patients
receiving care through the VA.
The HOPE clinical intervention differs from prior
work on diabetes and depression in three distinct ways.
First, the intervention allows patients to direct the focus
of treatment on diabetes or depression, or both, and
flexibly attends to the most pressing needs of patients.
Thus, it is not a stepped-care approach led by clinicians
but rather a patient-centered approach to the manage-
ment of diabetes and/or depression. Research suggests
that patients want to be involved in care decisions [42],
and patients’ involvement in choosing treatment content
is a foundational feature of HOPE. The intervention en-
gages patients to actively select and direct care practices,
hypothesized to increase patient motivation and confi-
dence to achieve self-initiated goals.
Second, the clinical intervention is conducted entirely
over the telephone. A recent review suggests that tele-
health services, including video-based services, hold the
potential to improve access to mental and physical health
care [43,44]. However, prior studies conducted within
the VA suggest that the effectiveness of telephone-
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limited treatment effects [45]. Additional research studies
on programs that provide telemental health treatment, like
HOPE, are needed.
As a third level of innovation, the clinical intervention,
as well as facets of the implementation strategy, seek to
increase the overall potency of outcomes through di-
rected efforts to communicate clinical information, e.g.,
presence of clinically significant depressive symptoms in
medically ill patients, to each patient’s primary care
treatment team. The inclusion of the patient’s existing
provider team is seen as critical, not only for improving
intervention potency but also for reconciling discrepant
definitions of treatment adherence and health-related
goals between patients and providers, and avoiding po-
tential clinical pitfalls related to hypoglycemia and wors-
ening emotional health.
From an implementation standpoint, the project en-
lists coach-based “interventions” to increase the fidelity
and adoption of HOPE by PACT providers with varying
levels of clinical experience. The training of nonmental
health experts is viewed as an important step to address
the limited supply of such providers in primary care and
in clinical settings outside academic medical centers.
To adequately train and support these nonmental health
specialists, the project team collaborated with stake-
holders to create print and online training materials,
a focused four-hour training workshop for clinician
coaches, and a comprehensive mentor program to en-
hance the professional development and clinical skills
of HOPE coaches.
As others have noted, strategies to improve access to
care must be balanced with the need to retain interven-
tion fidelity and effectiveness to keep these innovative
treatments from being “brilliant, but irrelevant” [46]. To
this end, HOPE attempts to balance the need to docu-
ment the effectiveness of the clinical intervention while
maintaining and supporting the use of the treatment in
real-world primary care settings.
Although not a primary or secondary outcome for the
trial, the project will explore clinician factors associated
with treatment fidelity, including clinician professional
background, prior diabetes treatment experience, prior
depression treatment experience, and time dedicated to
primary care relative to other professional duties. Fur-
ther, the inclusion of study coaches will allow an ex-
ploration of data to determine whether HOPE is more
effective when provided by the study coaches, who operate
outside the fast-paced, competing-demand setting of pri-
mary care. It is anticipated that study coaches will have
flexible schedules and greater ability to engage patients in
a timely manner, given their project funding and distance
from primary care. However, because study coaches are
physically distant from the primary care teams, PACTcoaches may evidence more frequent and higher-quality
communication with other clinicians within the PACT,
thus increasing the potency and patient-centeredness of
the intervention.
Because of the multifaceted nature of the trial, it is an-
ticipated that the HOPE intervention will provide mean-
ingful clinical information for the treatment of complex
patients with diabetes and depression. This trial will also
supply critical implementation data for the potential
use of telephone-based coaching interventions in the pri-
mary care setting. It is believed that hybrid effectiveness-
implementation designs, although complex and not without
sacrifices to internal validity, are useful for not only
reducing lag time between efficacy and implementation
but also for providing opportunities to identify potential
pitfalls, including information to better understand a nega-
tive clinical trial.
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